Acute macular neuroretinopathy following COVID-19 vaccination
Anders Djupesland Bøhler, Marianne Ekornes Strøm, Kjell Ulrik Sandvig, Morten C. Moe, Øystein Kalsnes Jørstad
Abstract
The complex immunological mechanisms of vaccines bring about an inevitable risk of immune-mediated adverse reactions. Of special interest in this time of epidemic is the safety of COVID-19 vaccines and, in particular, the emerging evidence that the ChAdOx1 nCoV-19 adenoviral vector vaccine from AstraZeneca can cause vaccine-induced immune thrombotic thrombocytopenia (VITT). We present the case of a patient who developed an acute paracentral scotoma after having received this vaccine.
Topics & Concepts
MedicineOphthalmologyUveitisCentral scotomaBlind spotIntraocular pressureAdverse effectCoronavirus disease 2019 (COVID-19)LesionVisual acuitySurgeryPathologyInternal medicineDiseaseInfectious disease (medical specialty)Artificial intelligenceComputer scienceRetinal and Optic ConditionsOcular Diseases and Behçet’s SyndromeCerebral Venous Sinus Thrombosis